Endocrinology Practice Questions

Q: A 35-year-old female with palpitations and diaphoresis who has a thyroid mass is most likely to be diagnosed with what condition?

Toxic adenoma. ***Toxic adenoma*** - **Palpitations** and **diaphoresis** are symptoms of **hyperthyroidism**, which can be caused by a toxic adenoma, a benign nodule that autonomously produces thyroid hormones [1]. - A palpable **thyroid mass** (nodule) in conjunction with hyperthyroid symptoms is highly suggestive of a toxic adenoma. *Thyroid carcinoma* - While a thyroid mass is present, **thyroid carcinoma** is typically **non-functional** and does not cause symptoms of hyperthyroidism like palpitations and diaphoresis. - Symptoms of thyroid cancer usually include a rapidly growing mass, hoarseness, dysphagia, or lymphadenopathy. *Thyroid cyst* - A **thyroid cyst** is a fluid-filled sac and is usually non-functional, meaning it does not produce thyroid hormones. - Therefore, it would not cause symptoms of **hyperthyroidism** such as palpitations and diaphoresis. *Hashimoto's thyroiditis* - **Hashimoto's thyroiditis** is an autoimmune condition that typically causes **hypothyroidism**, not hyperthyroidism [2]. - While it can present with a goiter or nodules, the associated symptoms would be fatigue, weight gain, and cold intolerance, not palpitations and diaphoresis [1].

Q: A 60-year-old female with hypothyroidism complains of increased lethargy and constipation. Her TSH level is elevated. What is the best management approach?

Increase levothyroxine dosage. ***Increase levothyroxine dosage*** - An **elevated TSH level** indicates that the thyroid gland is understimulated, despite the patient being on thyroid hormone replacement, implying **hypothyroidism** is not adequately controlled [1]. - Symptoms like **increased lethargy** and **constipation** are classic signs of persistent or worsening hypothyroidism, necessitating an increase in the **levothyroxine dose** [1] to achieve euthyroid status. *Reduce levothyroxine dose* - **Reducing levothyroxine** would worsen the underlying hypothyroidism, leading to a further increase in TSH and exacerbation of symptoms. - This action is appropriate only if the TSH were suppressed (low) or the patient showed signs of **hyperthyroidism** [1]. *Start liothyronine therapy* - **Liothyronine (T3)** is typically reserved for patients who do not respond adequately to levothyroxine (T4) therapy alone or in specific situations like myxedema coma. - In this case, optimizing the **levothyroxine dose** is the first-line and most effective approach; there is no indication that the patient requires T3. *Check TSH in 3 months* - While regular monitoring of TSH is crucial, simply waiting for 3 months without any intervention is inappropriate given the patient's existing **symptoms** and currently **elevated TSH**. - An immediate adjustment in the dose is needed [1], followed by re-evaluation of TSH and clinical status, typically within 6-8 weeks [1], to ensure therapeutic effectiveness.

Q: A 28-year-old male presents with muscle weakness and a history of difficulty climbing stairs. His serum potassium level is elevated. Which of the following conditions is most likely associated with hyperkalemia?

Addison's disease. **Addison's disease** - Addison's disease (primary adrenal insufficiency) leads to decreased production of **aldosterone**, a hormone responsible for sodium reabsorption and potassium excretion [2]. - The resulting **aldosterone deficiency** causes **hyperkalemia** (elevated potassium) and hyponatremia [1]. *Cushing's syndrome* - Cushing's syndrome is characterized by **excess cortisol** production, which often has mineralocorticoid effects, leading to **hypokalemia** (low potassium). - It typically presents with muscle weakness, but the serum potassium level would be low, not elevated [3]. *Primary hyperaldosteronism* - This condition involves **excessive aldosterone** production, causing increased sodium reabsorption and significant **potassium excretion** [1]. - This leads to **hypokalemia**, often with hypertension, which is the opposite of the patient's presentation [3]. *Hypothyroidism* - Severe hypothyroidism can sometimes cause mild electrolyte disturbances, but it is **not typically associated with significant hyperkalemia**. - Muscle weakness in hypothyroidism is common, but the underlying mechanism for hyperkalemia is not directly related to thyroid hormone deficiency.

Q: A 34-year-old woman presents with palpitations, weight loss, and heat intolerance. Physical examination reveals a diffusely enlarged thyroid. The initial laboratory test to confirm the diagnosis would be:

Thyroid-stimulating hormone (TSH) level. Thyroid-stimulating hormone (TSH) level - A **suppressed TSH level** is the most sensitive and specific initial screening test for **hyperthyroidism**, which is suggested by the patient's symptoms of palpitations, weight loss, and heat intolerance [2]. - In primary hyperthyroidism, the excessive production of thyroid hormones (T3 and T4) by the thyroid gland causes negative feedback on the pituitary, leading to a **decrease in TSH secretion** [1]. *Thyroid ultrasound* - A thyroid ultrasound provides information about the **structure** and **morphology** of the thyroid gland, such as nodularity or diffuse enlargement. - While it can confirm diffuse enlargement, it does not directly assess thyroid function or confirm the diagnosis of hyperthyroidism, which requires **biochemical testing** [1]. *Radioactive iodine uptake* - This test is used to determine the **etiology of hyperthyroidism** by measuring the thyroid gland's ability to take up iodine, helping differentiate between conditions like Graves' disease and thyroiditis [1]. - It is typically performed **after** hyperthyroidism has been biochemically confirmed (e.g., with TSH and free T4 levels) to guide treatment. *Serum thyroglobulin* - **Serum thyroglobulin** is primarily used as a tumor marker for monitoring patients with **differentiated thyroid cancer** after thyroidectomy. - Although it can be elevated in various thyroid conditions, it is not a direct measure of thyroid function and is therefore not the initial test to confirm hyperthyroidism.

Q: Which treatment option would be most effective in managing a patient with hypoaldosteronism?

Fludrocortisone administration. ***Fludrocortisone administration*** - **Fludrocortisone** is a synthetic **mineralocorticoid** that mimics the action of **aldosterone**, effectively replacing the deficient hormone in hypoaldosteronism. - It helps to **retain sodium** and water, and excrete potassium, thereby correcting the electrolyte imbalances associated with the condition [1]. *Sodium restriction* - Patients with **hypoaldosteronism** already have difficulty retaining sodium due to the lack of aldosterone, leading to **hyponatremia** and fluid loss [1]. - **Restricting sodium** intake would worsen these symptoms and is contraindicated. *Potassium supplements* - **Hypoaldosteronism** typically causes **hyperkalemia** (high potassium levels) because aldosterone normally promotes potassium excretion [1]. - Therefore, **potassium supplements** would exacerbate the existing hyperkalemia and are harmful. *Increased water intake* - While patients may experience some degree of dehydration due to sodium and water loss, simply **increasing water intake** without addressing the underlying sodium deficiency can lead to **dilutional hyponatremia** [2]. - This approach does not correct the core problem of mineralocorticoid deficiency and its electrolyte imbalances.

Q: A patient on long-term corticosteroid therapy presents with symptoms of adrenal insufficiency. What is the most appropriate management strategy for this condition?

Gradual tapering of corticosteroids. **Gradual tapering of corticosteroids** * **Gradual tapering** allows the **adrenal glands** to slowly resume their natural production of **cortisol**, preventing an **adrenal crisis** [1]. * **Abrupt cessation** leads to severe **adrenal insufficiency** due to the body's dependence on exogenous corticosteroids [1]. *I*mmediate cessation of corticosteroids * **Immediate cessation** can precipitate an **adrenal crisis**, a life-threatening condition characterized by **hypotension**, **shock**, and **electrolyte imbalance**. * This approach does not allow the **hypothalamic-pituitary-adrenal (HPA) axis** to recover, leading to severe cortisol deficiency [1]. *Switch to a different corticosteroid * Switching to a different corticosteroid would not address the underlying issue of **adrenal suppression** caused by long-term exogenous corticosteroid use. * The goal is to restore endogenous **cortisol production**, which requires reducing the overall corticosteroid load. *Addition of a mineralocorticoid * **Mineralocorticoid** replacement (e.g., fludrocortisone) is primarily indicated for **primary adrenal insufficiency** (e.g., Addison's disease), where **aldosterone production** is impaired. * In **secondary adrenal insufficiency** from long-term corticosteroid use, **aldosterone secretion** is usually preserved, as it is mainly regulated by the **renin-angiotensin system** [2].

Q: A 63-year-old female with a history of osteoporosis presents with worsening back pain and weight loss. MRI shows multiple vertebral fractures and compression deformities. Which treatment option is most appropriate for this patient?

Initiate bisphosphonates to reduce further bone loss. ***Initiate bisphosphonates to reduce further bone loss*** - Bisphosphonates are **first-line therapy** for osteoporosis, especially in patients with **vertebral fractures**, as they reduce bone resorption and the risk of future fractures [1]. - While weight loss and multiple fractures might raise concern for other etiologies, addressing the established **osteoporosis** with proven anti-resorptive therapy is the immediate and most appropriate step. *Calcium and vitamin D supplementation, defer further treatment* - While essential for bone health, **calcium and vitamin D supplementation alone** is insufficient to treat severe osteoporosis with existing vertebral fractures [1]. - Deferring further specific treatment for osteoporosis would leave the patient at **high risk for additional fractures** and worsening pain and disability [1]. *Spinal surgery, then reassess bone health* - **Spinal surgery** is considered for specific indications such as **spinal instability**, neurological compromise, or intractable pain not responding to conservative management, which are not explicitly mentioned as primary concerns. - Addressing the underlying **osteoporosis** with medication is crucial regardless of surgical intervention, as surgery does not treat the systemic bone disease. *Start anabolic agents like teriparatide to build bone mass* - **Anabolic agents like teriparatide** are potent therapies that stimulate bone formation and are highly effective; however, they are typically reserved for patients with very severe osteoporosis, those who have failed bisphosphonate therapy, or those with very high fracture risk. - Given the established osteoporosis and new fractures, initiating **bisphosphonates** is the more common and generally recommended initial approach before considering more specialized anabolic agents.

Q: A patient presents with signs of Cushing's syndrome. Which hormone is primarily responsible for this condition?

Cortisol. ***Cortisol*** - **Cushing's syndrome** is primarily caused by prolonged exposure to **high levels of cortisol**, leading to a characteristic set of signs and symptoms [1]. - **Cortisol** is a glucocorticoid hormone involved in stress response, metabolism, and immune function, and its excess disrupts these processes [1]. *Aldosterone* - **Aldosterone** is a mineralocorticoid hormone involved in **sodium and potassium balance**, and its excess leads to conditions like Conn's syndrome (**hyperaldosteronism**), not Cushing's syndrome [2]. - Symptoms of **hyperaldosteronism** include hypertension and hypokalemia, which differ from the classic features of Cushing's syndrome. *Thyroxine* - **Thyroxine** is a thyroid hormone that regulates metabolism; its excess causes **hyperthyroidism**, characterized by weight loss, tachycardia, and heat intolerance. - **Hyperthyroidism** symptoms are distinct from the weight gain, central obesity, and hyperglycemia seen in **Cushing's syndrome**. *Insulin* - **Insulin** is a pancreatic hormone responsible for glucose uptake by cells; its deficiency or resistance causes **diabetes mellitus**. - While **hyperglycemia** can occur in Cushing's syndrome due to cortisol's effects, **insulin itself is not the primary hormone** responsible for the syndrome's overall pathogenesis.

Q: A 60-year-old man is diagnosed with Conn's syndrome. What is the expected effect on his serum potassium levels?

Hypokalemia. ***Hypokalemia*** - **Conn's syndrome** (primary hyperaldosteronism) leads to excessive **aldosterone** secretion, which promotes potassium excretion in the kidneys [1]. - This increased renal potassium wasting results in **decreased serum potassium levels**, commonly presenting as hypokalemia [1], [2]. *Hyperkalemia* - **Hyperkalemia** (high potassium) is the opposite of what occurs in Conn's syndrome; conditions like **adrenal insufficiency** (Addison's disease) or renal failure are associated with hyperkalemia due to decreased aldosterone effect or inability to excrete potassium. - Conn's syndrome causes increased **aldosterone** activity, actively moving potassium out of the body [1]. *Normokalemia* - While some patients with primary hyperaldosteronism can initially present with **normokalemia**, sustained oversecretion of **aldosterone** typically leads to some degree of **potassium depletion** as the kidneys continue to excrete it [2]. - **Normokalemia** would not be the *expected* long-term effect in untreated Conn's syndrome. *Hypernatremia* - Conn's syndrome is characterized by increased **aldosterone** secretion, which primarily causes **sodium retention** and **potassium excretion** [1]. - While sodium retention occurs, it often leads to **volume expansion** and **suppression of ADH**, preventing significant **hypernatremia**; instead, patients often have normal or mildly elevated serum sodium levels [2].

Question 1

A 35-year-old female with palpitations and diaphoresis who has a thyroid mass is most likely to be diagnosed with what condition?

Accepted Answer

Toxic adenoma

Answer

Thyroid carcinoma

Answer

Thyroid cyst

Answer

Hashimoto's thyroiditis

Question 2

A patient with a history of type 2 diabetes and peripheral neuropathy presents with a red, swollen left foot, with no open wounds present. What is the most appropriate treatment?

Accepted Answer

Immediate immobilization and non-weight bearing with urgent imaging

Answer

Blood sugar optimization and routine follow-up

Answer

Oral antibiotics and close monitoring

Answer

Topical anti-inflammatory cream and elevation

Question 3

A 60-year-old female with hypothyroidism complains of increased lethargy and constipation. Her TSH level is elevated. What is the best management approach?

Accepted Answer

Increase levothyroxine dosage

Answer

Reduce levothyroxine dose

Answer

Start liothyronine therapy

Answer

Check TSH in 3 months

Question 4

A 28-year-old male presents with muscle weakness and a history of difficulty climbing stairs. His serum potassium level is elevated. Which of the following conditions is most likely associated with hyperkalemia?

Accepted Answer

Addison's disease

Answer

Hypothyroidism

Answer

Primary hyperaldosteronism

Answer

Cushing's syndrome

Question 5

A 34-year-old woman presents with palpitations, weight loss, and heat intolerance. Physical examination reveals a diffusely enlarged thyroid. The initial laboratory test to confirm the diagnosis would be:

Accepted Answer

Thyroid-stimulating hormone (TSH) level

Answer

Thyroid ultrasound

Answer

Radioactive iodine uptake

Answer

Serum thyroglobulin

Question 6

Which treatment option would be most effective in managing a patient with hypoaldosteronism?

Accepted Answer

Fludrocortisone administration

Answer

Sodium restriction

Answer

Potassium supplements

Answer

Increased water intake

Question 7

A patient on long-term corticosteroid therapy presents with symptoms of adrenal insufficiency. What is the most appropriate management strategy for this condition?

Accepted Answer

Gradual tapering of corticosteroids

Answer

Immediate cessation of corticosteroids

Answer

Switch to a different corticosteroid

Answer

Addition of a mineralocorticoid

Question 8

A 63-year-old female with a history of osteoporosis presents with worsening back pain and weight loss. MRI shows multiple vertebral fractures and compression deformities. Which treatment option is most appropriate for this patient?

Accepted Answer

Initiate bisphosphonates to reduce further bone loss

Answer

Calcium and vitamin D supplementation, defer further treatment

Answer

Spinal surgery, then reassess bone health

Answer

Start anabolic agents like teriparatide to build bone mass

Question 9

A patient presents with signs of Cushing's syndrome. Which hormone is primarily responsible for this condition?

Accepted Answer

Cortisol

Answer

Aldosterone

Answer

Thyroxine

Answer

Insulin

Question 10

A 60-year-old man is diagnosed with Conn's syndrome. What is the expected effect on his serum potassium levels?

Accepted Answer

Hypokalemia

Answer

Hyperkalemia

Answer

Normokalemia

Answer

Hypernatremia

Endocrinology — MCQs

Endocrinology — MCQs

On this page

Practice by Chapter

Want unlimited practice?